From Disruption to Delivery: Keeping Clinical Trials Moving and Navigating Supply Chain Disruptions in Uncertain Times

In our latest podcast series Zayheda Khan, Oximio’s Chief Commercial Officer and UK Managing Director, takes a deep dive into a critical topic – the growing impact of geopolitical instability on clinical trial supply chains.

In 2026, we’re seeing increasing disruption to global logistics networks. Air cargo routes are changing, transit hubs are under pressure, and for clinical trials, that creates real challenges, not just operationally, but for patients relying on timely access to investigational medicines.

For sponsors and CROs, this isn’t just about delays, it’s about maintaining cold-chain integrity, ensuring regulatory compliance, and ultimately protecting patient outcomes and trial continuity.

What does all this disruption mean for clinical trials, and what can be done to ensure continuity, protect timelines, and most importantly, ensure patients continue to receive the treatments they need?

Join Zayheda as she explains what’s happening on the ground.

Supply Chain Solutions for Clinical Trials

For further information on any of our supply chain solutions, why not explore our website or contact us to find out how we can support your clinical trial.